Sung‐Liang Yu

12.2k total citations · 2 hit papers
201 papers, 7.6k citations indexed

About

Sung‐Liang Yu is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sung‐Liang Yu has authored 201 papers receiving a total of 7.6k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Molecular Biology, 56 papers in Cancer Research and 54 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sung‐Liang Yu's work include Lung Cancer Treatments and Mutations (45 papers), MicroRNA in disease regulation (27 papers) and Cancer-related molecular mechanisms research (21 papers). Sung‐Liang Yu is often cited by papers focused on Lung Cancer Treatments and Mutations (45 papers), MicroRNA in disease regulation (27 papers) and Cancer-related molecular mechanisms research (21 papers). Sung‐Liang Yu collaborates with scholars based in Taiwan, United States and Singapore. Sung‐Liang Yu's co-authors include Pan‐Chyr Yang, Jeremy J.W. Chen, Hsuan‐Yu Chen, Huei‐Wen Chen, Kang‐Yi Su, Bing‐Ching Ho, Gee‐Chen Chang, Gee‐Chen Chang, Ang Yuan and Wing‐Kai Chan and has published in prestigious journals such as New England Journal of Medicine, Nucleic Acids Research and Nature Communications.

In The Last Decade

Sung‐Liang Yu

193 papers receiving 7.4k citations

Hit Papers

A Five-Gene Signature and Clinical Outcome in Non–Small-C... 2007 2026 2013 2019 2007 2012 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A Five-Gene Signature and Clinical Outcome in Non–Small-Cell Lung Cancer
    2007 693 citations Hsuan‐Yu Chen, Sung‐Liang Yu et al. profile →
  2. Pretreatment Epidermal Growth Factor Receptor ( EGFR ) T790M Mutation Predicts Shorter EGFR Tyrosine Kinase Inhibitor Response Duration in Patients With Non–Small-Cell Lung Cancer
    2012 429 citations Kang‐Yi Su, Hsuan‐Yu Chen et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sung‐Liang Yu Taiwan 43 4.1k 2.4k 1.9k 1.8k 841 201 7.6k
Na Liu China 49 5.6k 1.4× 3.7k 1.5× 1.8k 1.0× 1.5k 0.8× 899 1.1× 319 9.1k
Erik A.C. Wiemer Netherlands 50 4.8k 1.2× 2.1k 0.9× 2.4k 1.3× 1.1k 0.6× 510 0.6× 158 8.2k
Chen Liang China 47 4.5k 1.1× 2.4k 1.0× 2.9k 1.5× 1.5k 0.8× 1.7k 2.0× 152 7.9k
Guosheng Ren China 41 3.6k 0.9× 1.9k 0.8× 1.7k 0.9× 671 0.4× 716 0.9× 188 6.4k
Yanqing Ding China 48 5.5k 1.3× 3.5k 1.5× 1.8k 1.0× 791 0.4× 870 1.0× 191 9.4k
Dan Li China 45 5.6k 1.3× 3.6k 1.5× 1.5k 0.8× 837 0.5× 723 0.9× 390 8.7k
Liang Chen China 43 4.1k 1.0× 1.0k 0.4× 1.8k 1.0× 1.7k 0.9× 869 1.0× 217 7.3k
Lorraine O’Driscoll Ireland 47 5.4k 1.3× 3.0k 1.3× 1.9k 1.0× 998 0.5× 732 0.9× 136 9.1k
Catherine O′Brien Canada 27 3.9k 0.9× 1.8k 0.8× 4.0k 2.2× 899 0.5× 961 1.1× 79 7.6k
Xiaohong Wang China 50 5.2k 1.3× 2.9k 1.2× 1.4k 0.7× 1.0k 0.6× 1.3k 1.5× 273 9.1k

Countries citing papers authored by Sung‐Liang Yu

Since Specialization
Citations

This map shows the geographic impact of Sung‐Liang Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sung‐Liang Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sung‐Liang Yu more than expected).

Fields of papers citing papers by Sung‐Liang Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sung‐Liang Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sung‐Liang Yu. The network helps show where Sung‐Liang Yu may publish in the future.

Co-authorship network of co-authors of Sung‐Liang Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Sung‐Liang Yu. A scholar is included among the top collaborators of Sung‐Liang Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sung‐Liang Yu. Sung‐Liang Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tseng, Ching‐Hung, Sunny H. Wong, Jun Yu, et al.. (2025). Development of live biotherapeutic products: a position statement of Asia-Pacific Microbiota Consortium. Gut. 74(5). 706–713. 9 indexed citations
2.
Chang, Wen‐Hsin, Yi‐Ju Chen, Yi‐Jing Hsiao, et al.. (2022). Reduced symmetric dimethylation stabilizes vimentin and promotes metastasis in MTAP‐ deficient lung cancer. EMBO Reports. 23(8). e54265–e54265. 10 indexed citations
3.
Chang, Wen‐Hsin, Jun Zhang, David C.H. Yang, et al.. (2022). MTAP deficiency contributes to immune landscape remodelling and tumour evasion. Immunology. 168(2). 331–345. 9 indexed citations
4.
Lin, Mong‐Wei, Kang‐Yi Su, Te‐Jen Su, et al.. (2018). Clinicopathological and genomic comparisons between different histologic components in combined small cell lung cancer and non-small cell lung cancer. Lung Cancer. 125. 282–290. 46 indexed citations
5.
Su, Kang‐Yi, Jeng‐Sen Tseng, Tsung‐Ying Yang, et al.. (2018). Mutational monitoring of EGFR T790M in cfDNA for clinical outcome prediction in EGFR-mutant lung adenocarcinoma. PLoS ONE. 13(11). e0207001–e0207001. 20 indexed citations
6.
Chang, Gee‐Chen, Yi‐Ju Chen, Yi‐Chiung Hsu, et al.. (2017). FAM198B Is Associated with Prolonged Survival and Inhibits Metastasis in Lung Adenocarcinoma via Blockage of ERK-Mediated MMP-1 Expression. Clinical Cancer Research. 24(4). 916–926. 26 indexed citations
7.
Leu, Jia-Shiun, Meiling Chen, Sung‐Liang Yu, et al.. (2017). SP110b Controls Host Immunity and Susceptibility to Tuberculosis. American Journal of Respiratory and Critical Care Medicine. 195(3). 369–382. 33 indexed citations
8.
Chen, Chun-Chieh, Hsuan‐Yu Chen, Kang‐Yi Su, et al.. (2014). Shisa3 is Associated with Prolonged Survival Through Promoting β-Catenin Degradation in Lung Cancer. American Journal of Respiratory and Critical Care Medicine. 190(4). 433–444. 33 indexed citations
9.
10.
Chen, Ching‐Hsien, et al.. (2012). A Novel Function of YWHAZ/β-Catenin Axis in Promoting Epithelial–Mesenchymal Transition and Lung Cancer Metastasis. Molecular Cancer Research. 10(10). 1319–1331. 82 indexed citations
11.
Tang, Shye-Jye, Guang-Huan Sun, Teh‐Ying Chou, et al.. (2012). Galectin-1 Promotes Lung Cancer Progression and Chemoresistance by Upregulating p38 MAPK, ERK, and Cyclooxygenase-2. Clinical Cancer Research. 18(15). 4037–4047. 136 indexed citations
12.
Su, Kang‐Yi, Hsuan‐Yu Chen, Ker-Chau Li, et al.. (2012). Pretreatment Epidermal Growth Factor Receptor ( EGFR ) T790M Mutation Predicts Shorter EGFR Tyrosine Kinase Inhibitor Response Duration in Patients With Non–Small-Cell Lung Cancer. Journal of Clinical Oncology. 30(4). 433–440. 429 indexed citations breakdown →
13.
Ou, Da‐Liang, Ying‐Chun Shen, Sung‐Liang Yu, et al.. (2010). Induction of DNA Damage-Inducible Gene GADD45β Contributes to Sorafenib-Induced Apoptosis in Hepatocellular Carcinoma Cells. Cancer Research. 70(22). 9309–9318. 68 indexed citations
14.
Chen, Pai‐Sheng, Gunnar Johansson, Chia‐Yu Chu, et al.. (2010). MicroRNA-519c Suppresses Hypoxia-Inducible Factor-1α Expression and Tumor Angiogenesis. Cancer Research. 70(7). 2675–2685. 168 indexed citations
15.
Tsai, Meng-Feng, Kang‐Yi Su, Sung‐Liang Yu, et al.. (2010). Slug Confers Resistance to the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor. American Journal of Respiratory and Critical Care Medicine. 183(8). 1071–1079. 146 indexed citations
16.
Hsu, Yi‐Chiung, Shinsheng Yuan, Hsuan‐Yu Chen, et al.. (2009). A Four-Gene Signature from NCI-60 Cell Line for Survival Prediction in Non–Small Cell Lung Cancer. Clinical Cancer Research. 15(23). 7309–7315. 42 indexed citations
17.
18.
Chen, Hsuan‐Yu, Sung‐Liang Yu, Gee-Chen Chang, et al.. (2008). MicroRNA signature predicts survival and relapse in lung cancer. Cancer Research. 68. 4432–4432. 1 indexed citations
19.
Pan, Szu‐Hua, Shuenn-Chen Yang, Sung‐Liang Yu, et al.. (2008). Claudin-1 Is a Metastasis Suppressor and Correlates with Clinical Outcome in Lung Adenocarcinoma. American Journal of Respiratory and Critical Care Medicine. 179(2). 123–133. 146 indexed citations
20.
Yu, Sung‐Liang, Hsuan‐Yu Chen, Pan‐Chyr Yang, & Jeremy J.W. Chen. (2007). Unique MicroRNA Signature and Clinical Outcome of Cancers. DNA and Cell Biology. 26(5). 283–292. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Na Liu Breakdown of academic impact, for papers by Erik A.C. Wiemer Breakdown of academic impact, for papers by Chen Liang Breakdown of academic impact, for papers by Guosheng Ren Breakdown of academic impact, for papers by Yanqing Ding Breakdown of academic impact, for papers by Dan Li Breakdown of academic impact, for papers by Liang Chen Breakdown of academic impact, for papers by Lorraine O’Driscoll Breakdown of academic impact, for papers by Catherine O′Brien Breakdown of academic impact, for papers by Xiaohong Wang
Rankless by CCL
2026